Valion Bio (VBIO) Change in Cash (2021 - 2025)

Valion Bio has reported Change in Cash for 5 years, with the latest figure at $9.2 million in Q4 2025.

• On a quarterly basis, Change in Cash rose 5017.11% year-over-year to $9.2 million in Q4 2025; TTM through Dec 2025 was $10.6 million, a 864.03% increase from a year earlier, with the FY2025 full-year figure at $10.6 million, up 864.03% from the prior year.
• Change in Cash was $9.2 million for Q4 2025 at Valion Bio, up from $2.3 million in the prior quarter.
• The five-year high for Change in Cash was $12.1 million in Q4 2021, with the low at -$2.8 million in Q4 2022.
• Average Change in Cash over 5 years is $580050.0, with a median of -$609500.0 recorded in 2021.
• The sharpest annual moves came in 2022 and 2025: Change in Cash plunged 389.64% in 2022, then surged 5017.11% in 2025.
• Over 5 years, Change in Cash stood at $12.1 million in 2021, then slumped by 123.18% to -$2.8 million in 2022, then jumped by 36.89% to -$1.8 million in 2023, then surged by 89.46% to -$187000.0 in 2024, then soared by 5017.11% to $9.2 million in 2025.
• The last three Change in Cash figures came in at $9.2 million (Q4 2025), $2.3 million (Q3 2025), and $515000.0 (Q2 2025), per Business Quant data.